Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Prolactinoma 1Pituitary ACTH Hypersecretion 1Gigantism 1Congenital Abnormalities 1Combined Pituitary Hormone Deficiency 1Carcinogenesis 1Acromegaly 1

Interventions

Cytarabine 28Etoposide 12Daunorubicin 11fludarabine phosphate 10Busulfan 10Peripheral Blood Stem Cell Transplantation 9tipifarnib 8Vorinostat 7Mitoxantrone 7Cyclosporine 7laromustine 6alvocidib 6Filgrastim 6Decitabine 6Cyclophosphamide 6Antilymphocyte Serum 6Idarubicin 5Methotrexate 4Bortezomib 4valspodar 3sargramostim 3romidepsin 3Radiotherapy 3Polymerase Chain Reaction 3Mycophenolic Acid 3Methylprednisolone 3Melphalan 3Gene Expression Profiling 3tanespimycin 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Congenital Abnormalities × Tissue Banks × Clear all
NCT00001595 2026-06-01

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
2,000 enrolled
Endocrine

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡